Notice: This company has been marked as potentially delisted and may not be actively trading. D8 (DEH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends DEH vs. ENOV, CDRE, ESTA, AVNS, SMTI, AVR, INGN, LAKE, ZJYL, and MLSSShould you be buying D8 stock or one of its competitors? The main competitors of D8 include Enovis (ENOV), Cadre (CDRE), Establishment Labs (ESTA), Avanos Medical (AVNS), Sanara MedTech (SMTI), Anteris Technologies Global (AVR), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), and Milestone Scientific (MLSS). D8 vs. Enovis Cadre Establishment Labs Avanos Medical Sanara MedTech Anteris Technologies Global Inogen Lakeland Industries Jin Medical International Milestone Scientific D8 (NYSE:DEH) and Enovis (NYSE:ENOV) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership. Does the MarketBeat Community prefer DEH or ENOV? Enovis received 29 more outperform votes than D8 when rated by MarketBeat users. CompanyUnderperformOutperformD8N/AN/AEnovisOutperform Votes2961.70% Underperform Votes1838.30% Is DEH or ENOV more profitable? D8 has a net margin of 0.00% compared to Enovis' net margin of -5.95%. Enovis' return on equity of 4.39% beat D8's return on equity.Company Net Margins Return on Equity Return on Assets D8N/A N/A N/A Enovis -5.95%4.39%2.80% Do analysts rate DEH or ENOV? Enovis has a consensus target price of $58.75, indicating a potential upside of 37.38%. Given Enovis' stronger consensus rating and higher probable upside, analysts plainly believe Enovis is more favorable than D8.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score D8 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Enovis 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media favor DEH or ENOV? In the previous week, Enovis had 5 more articles in the media than D8. MarketBeat recorded 5 mentions for Enovis and 0 mentions for D8. Enovis' average media sentiment score of 1.24 beat D8's score of -0.73 indicating that Enovis is being referred to more favorably in the news media. Company Overall Sentiment D8 Negative Enovis Positive Do insiders & institutionals believe in DEH or ENOV? 65.4% of D8 shares are held by institutional investors. Comparatively, 98.5% of Enovis shares are held by institutional investors. 2.4% of Enovis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings and valuation, DEH or ENOV? D8 has higher earnings, but lower revenue than Enovis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioD8N/AN/A-$9.46MN/AN/AEnovis$1.71B1.42-$33.26M-$2.19-19.53 SummaryEnovis beats D8 on 11 of the 13 factors compared between the two stocks. Get D8 News Delivered to You Automatically Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DEH vs. The Competition Export to ExcelMetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE ExchangeMarket Cap$620.14M$10.39B$5.83B$20.22BDividend YieldN/A1.39%4.75%3.64%P/E RatioN/A18.8726.8134.95Price / SalesN/A47.39428.3217.44Price / CashN/A19.7038.0120.26Price / Book119.835.397.644.80Net Income-$9.46M$284.66M$3.19B$1.02B D8 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DEHD8N/A$14.38-1.6%N/A+3,981.7%$620.14MN/A0.003ENOVEnovis3.4325 of 5 stars$43.89+0.4%$64.83+47.7%-33.0%$2.50B$1.71B-20.046,550Short Interest ↓Positive NewsCDRECadre2.9021 of 5 stars$35.14-1.6%$39.67+12.9%-6.1%$1.43B$482.53M42.342,435ESTAEstablishment Labs2.6696 of 5 stars$36.08+7.4%$60.60+68.0%-9.1%$1.01B$165.15M-13.98960Upcoming EarningsAVNSAvanos Medical3.3824 of 5 stars$16.55-0.5%N/A-20.9%$760.64M$673.30M48.683,771Upcoming EarningsShort Interest ↓SMTISanara MedTech2.1571 of 5 stars$35.02-0.7%$47.00+34.2%-11.3%$306.08M$64.99M-35.3760AVRAnteris Technologies GlobalN/A$7.99+1.9%$16.50+106.5%N/A$287.16MN/A0.00138Gap DownINGNInogen2.5158 of 5 stars$10.64-0.2%$7.00-34.2%+5.8%$253.45M$315.66M-4.731,030LAKELakeland Industries4.7105 of 5 stars$24.03-1.9%$27.50+14.4%+36.3%$228.29M$124.69M-267.001,750ZJYLJin Medical InternationalN/A$0.86+0.5%N/A-90.6%$134.65M$23.50M0.00245News CoverageHigh Trading VolumeMLSSMilestone Scientific0.7985 of 5 stars$1.21+0.8%$1.25+3.3%+51.8%$94.25M$9.83M-17.2830News CoverageGap Up Related Companies and Tools Related Companies ENOV Competitors CDRE Competitors ESTA Competitors AVNS Competitors SMTI Competitors AVR Competitors INGN Competitors LAKE Competitors ZJYL Competitors MLSS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:DEH) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding D8 Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share D8 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
